What is the recommended insulin protocol for initiating therapy in patients with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Insulin Protocol for Initiating Therapy in Diabetes

For patients with type 2 diabetes requiring insulin therapy, basal insulin should be initiated at 10 units per day or 0.1-0.2 units/kg/day, depending on the degree of hyperglycemia. 1, 2

Initial Insulin Selection and Dosing

Basal Insulin Initiation

  • Basal insulin alone is the most convenient initial insulin regimen for most patients with type 2 diabetes 2, 1
  • Start with 10 units per day or 0.1-0.2 units/kg/day of basal insulin, titrating over days to weeks as needed 2, 3
  • Long-acting insulin analogs (glargine, detemir, degludec) are preferred over NPH insulin due to lower risk of hypoglycemia 2, 4
  • Detemir has shown significantly lower risk of severe hypoglycemia compared to NPH insulin in real-world studies 4
  • Continue metformin when initiating insulin therapy 2, 1

Special Circumstances for Immediate Insulin Initiation

  • Consider immediate insulin therapy when 1, 2:
    • HbA1c ≥10% (86 mmol/mol)
    • Blood glucose ≥300 mg/dL (16.7 mmol/L)
    • Symptoms of hyperglycemia are present
    • Evidence of ongoing catabolism (weight loss, ketosis)
    • Type 1 diabetes is suspected

Titration and Adjustment

Basal Insulin Titration

  • Increase dose by 10-15% or 2-4 units once or twice weekly until fasting glucose target is achieved 2
  • Empower patients with self-titration algorithms based on self-monitoring to improve glycemic control 2, 1
  • Watch for clinical signs of overbasalization 2:
    • Basal dose >0.5 units/kg
    • High bedtime-to-morning glucose differential
    • Hypoglycemia (aware or unaware)
    • High glucose variability

When to Add Prandial Insulin

  • If basal insulin has been optimally titrated (or dose >0.5 units/kg/day) and HbA1c remains above target, consider adding prandial insulin 2, 5
  • Before adding prandial insulin, consider adding a GLP-1 receptor agonist if not already being used 2
  • When initiating prandial insulin, start with 4 units, 0.1 units/kg, or 10% of the basal dose before the largest meal or meal with greatest postprandial excursion 5, 2
  • When adding significant prandial insulin doses, consider decreasing basal insulin 2

Insulin Regimen Options

Basal-Bolus Regimen

  • Preferred approach for patients with type 1 diabetes and some with type 2 diabetes 6
  • Consists of basal insulin (once or twice daily) plus rapid-acting insulin before meals 2
  • Rapid-acting insulin analogs (lispro, aspart, glulisine) are preferred for mealtime coverage due to quicker onset of action 5, 2

Premixed Insulin Options

  • Consider premixed insulin products for patients who may benefit from simpler dosing 2
  • Contains fixed proportions of basal and prandial insulin components 2
  • Main disadvantage is requiring relatively fixed meal schedule and carbohydrate content 2

Medication Management with Insulin Initiation

Concomitant Medications

  • Continue metformin when initiating insulin therapy 1, 2
  • Consider discontinuing sulfonylureas, DPP-4 inhibitors, and GLP-1 receptor agonists when using complex insulin regimens beyond basal insulin 1, 2
  • Thiazolidinediones or SGLT-2 inhibitors may improve control and reduce total daily insulin dose 2

Common Pitfalls to Avoid

  • Delaying insulin therapy in patients not achieving glycemic goals 1
  • Using insulin as a threat or describing it as a sign of personal failure 1, 2
  • Overbasalization (continuing to increase basal insulin when prandial coverage is needed) 2
  • Inadequate patient education on self-monitoring, diet, and hypoglycemia management 1, 2
  • Using sliding-scale insulin alone without basal insulin 7

Patient Education

  • Provide comprehensive education on self-monitoring of blood glucose, diet, and hypoglycemia recognition/treatment 1, 2
  • Explain the progressive nature of type 2 diabetes and the role of insulin therapy 1
  • Teach proper injection technique and site rotation to prevent lipohypertrophy 6
  • Instruct on self-titration algorithms to improve glycemic control 2, 1

References

Guideline

Initial Insulin Therapy Dosing and Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy for Type 2 Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Research

Addressing hyperglycemia from hospital admission to discharge.

Current medical research and opinion, 2010

Related Questions

Can Total Daily Dose (TDD) of insulin be calculated daily based on basal, bolus, and correction doses to adjust new basal and bolus dosing for hospitalized patients with impaired glucose control?
What is the recommended intravenous (IV) insulin infusion rate for managing hyperglycemia?
What is the most appropriate treatment for a 17-year-old male with type 2 diabetes mellitus (T2DM), presenting with hyperglycemia, polyuria, polydipsia, and significant weight loss, after discontinuing metformin (Metformin) therapy 6 months prior?
Can I start a patient with a hemoglobin A1c (HbA1c) level of 16.1% on 20 units of basal insulin if they are already on metformin (Metformin) 500 mg extended release (ER)?
What is the difference between regular insulin (e.g. Humulin R, Novolin R) and long-acting insulin (e.g. Lantus, Levemir) for diabetes management?
What are the mechanisms of the skin's first line of defense, including mechanical and biochemical (biochemical) barriers?
What is the next step for a patient with a chronic total occlusion of the Right Coronary Artery (RCA) who is now experiencing shortness of breath and fatigue after being asymptomatic for two weeks?
Will a fracture of the L4 (Lumbar Vertebra 4) vertebra cause an increase in C-Reactive Protein (CRP) levels?
What does a slightly elevated white blood cell (WBC) count and neutrophils on a complete blood count (CBC) indicate?
What is the management of postcoital headache and visual changes with an exertional component?
What are the emergency medicine treatment options for constipation during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.